Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Clinical trial NCT00788892 · COMPLETED

Trial details

NCT number: NCT00788892
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2008-10-01
Primary completion: 2010-06-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.